AIIMS recalled disposable syringes over quality complaints; no patient harm reported: Health Ministry
Action has been initiated against the manufacturers; the entire affected stock has been replaced
The All India Institute of Medical Sciences (AIIMS) in Delhi issued a recall for certain batches of disposable syringes earlier this year following complaints related to the quality of the products, according to the Union Health Ministry's written reply to Parliament on August 5, 2026. The recall was undertaken as a precautionary measure to ensure patient safety, following reports of quality issues with the syringes manufactured by Noble Pharmacare Ltd. and Veekay Surgicals.
No adverse effects on patients were reported due to the affected batches, the Ministry stated. Both manufacturers have been issued show-cause notices, and the entire stock of the affected syringe batches has been replaced with fresh supplies. The Ministry informed that AIIMS follows strict procurement and quality inspection protocols for medical devices, including random sampling and verification during supply.
An inspection committee verifies received supplies against samples provided during the bidding process, rejecting any batch that does not meet approved specifications. To prevent future incidents, AIIMS has established a dedicated Patient Safety and Quality Cell tasked with conducting root-cause analyses of such issues and recommending corrective measures.
The government did not provide details on the nature of the quality defects that triggered the recall or the exact number of syringe batches withdrawn.
Written by urgent.news from The Hindu's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
